Flavocoxid

WikiDoc Resources for Flavocoxid

Articles

Most recent articles on Flavocoxid

Most cited articles on Flavocoxid

Review articles on Flavocoxid

Articles on Flavocoxid in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Flavocoxid

Images of Flavocoxid

Photos of Flavocoxid

Podcasts & MP3s on Flavocoxid

Videos on Flavocoxid

Evidence Based Medicine

Cochrane Collaboration on Flavocoxid

Bandolier on Flavocoxid

TRIP on Flavocoxid

Clinical Trials

Ongoing Trials on Flavocoxid at Clinical Trials.gov

Trial results on Flavocoxid

Clinical Trials on Flavocoxid at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Flavocoxid

NICE Guidance on Flavocoxid

NHS PRODIGY Guidance

FDA on Flavocoxid

CDC on Flavocoxid

Books

Books on Flavocoxid

News

Flavocoxid in the news

Be alerted to news on Flavocoxid

News trends on Flavocoxid

Commentary

Blogs on Flavocoxid

Definitions

Definitions of Flavocoxid

Patient Resources / Community

Patient resources on Flavocoxid

Discussion groups on Flavocoxid

Patient Handouts on Flavocoxid

Directions to Hospitals Treating Flavocoxid

Risk calculators and risk factors for Flavocoxid

Healthcare Provider Resources

Symptoms of Flavocoxid

Causes & Risk Factors for Flavocoxid

Diagnostic studies for Flavocoxid

Treatment of Flavocoxid

Continuing Medical Education (CME)

CME Programs on Flavocoxid

International

Flavocoxid en Espanol

Flavocoxid en Francais

Business

Flavocoxid in the Marketplace

Patents on Flavocoxid

Experimental / Informatics

List of terms related to Flavocoxid

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

## Overview[edit | edit source]

Flavocoxid is a brand name for a blend of flavenoids that has recently become a tool in the treatment of osteoarthritis.[1] It is sold under the brand name Limbrel, manufactured by Primus Pharmaceuticals. The capsules also include the ingredient zinc gluconate. Limbrel is used as a nutritional therapy to help reduce inflammation. Flavocoxid has been associated with liver toxicity in prospective clinical trials published in the Annals of Internal Medicine.[2]

## References[edit | edit source]

1. ↑ "Limbrel500".
2. ↑ http://www.news-medical.net/news/20120625/Flavocoxid-liver-damage-reported.aspx